Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic Alongside Bill & Melinda Gates Foundation

Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic Alongside Bill & Melinda Gates Foundation

Categories :

By citiesabc news
coronavirus

PR: Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic Alongside Bill & Melinda Gates Foundation

Collaboration to address product development and scale-up challenges posed by the current pandemic

SEATTLE, March 25, 2020 – Today, a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for COVID-19. The life sciences industry brings a range of assets, resources, and expertise needed to identify effective and scalable solutions to the pandemic, which is affecting billions worldwide. The impact on health systems, economies, and livelihoods is profound, and an effective response requires an unprecedented collaboration across governments, academia, the private sector, and the philanthropic community.

As co-chair of a consortium life science companies headquartered across three continents, Vas Narasimhan, chief executive officer of Novartis, said, “We feel a deep shared responsibility to see if there are specific areas where collaboration across the life sciences industry and the Bill & Melinda Gates Foundation can accelerate solutions to this pandemic. In addition to the individual contributions companies are already making, collective action is critical to ensure any promising studies into vaccines, drugs, and diagnostics are quickly scaled to people around the world who are affected by this pandemic.”

Trials of existing drugs, diagnostic tests, compounds, and investigational vaccines have begun across the globe to identify interventions that could slow or end the pandemic. Products that demonstrate efficacy will require clinical study, scale up of manufacturing, and distribution if proven effective. The life sciences industry has extensive experience in managing these processes for products that reach billions of people every day.

“We know that the private sector is where the technical skills and know-how regarding discovery, clinical trials, and commercialization sit,” said Mark Suzman, chief executive officer of the Bill & Melinda Gates Foundation. “We look to harness that knowledge and experience—combining it where possible—to connect with national regulators and the World Health Organization to see if we can help flatten the curve of this epidemic and make sure the results reach everyone around the world, particularly those at highest risk and the poorest.”

Following a conference call with Gates Foundation leadership earlier this month, companies are working to identify concrete actions that will accelerate treatments, vaccines, and diagnostics to the field. As a first step, 15 companies have agreed to share their proprietary libraries of molecular compounds that already have some degree of safety and activity data with the COVID-19 Therapeutics Accelerator—launched by the Gates Foundation, Wellcome, and Mastercard two weeks ago—to quickly screen them for potential use against COVID-19. Successful hits would move rapidly into in vivo trials in as little as two months.

“This is an encouraging start in a critical area, because if any of these compounds are shown to be effective against COVID-19, it dramatically accelerates the path to product approval and scale up,” said Suzman. “While each of the consortium’s partners will also be pursuing independent efforts with national governments and others, we are optimistic that this unprecedented collaboration will provide a platform for a fundamentally different kind of partnership to help address this global health emergency.”

Companies participating in the collaboration include BD, bioMérieux, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck (known as MSD outside the U.S. and Canada), Merck KGaA, Novartis, Pfizer, and Sanofi.

About the Bill & Melinda Gates Foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

Tags

Why City Real Estate Investment Is on the Rise?

Why City Real Estate Investment Is on the Rise?

Feb 21, 2024

Maximizing Urban Space: Commercial Roofing Solutions For City Centers

Feb 21, 2024
Smart Factories: An Unexplored Internship Goldmine for Engineering Students

Smart Factories: An Unexplored Internship Goldmine for Engineering Students

Feb 21, 2024
6 Lessons from New Business Owners’ Common Missteps

6 Lessons from New Business Owners’ Common Missteps

Feb 19, 2024
The Evolution of Electric Vehicle Technology: The Key Innovations

The Evolution of Electric Vehicle Technology: The Key Innovations

Feb 18, 2024
The Essential Guide to Partnering with an Equity Firm for Business Growth

The Essential Guide to Partnering with an Equity Firm for Business Growth

Feb 18, 2024
Understanding Data Centers & Its Structure: 6 Practical Tips from the Pros

Understanding Data Centers & Its Structure: 6 Practical Tips from the Pros

Feb 15, 2024
Leveraging Blockchain Tech To Transition Businesses To Web 3.0: Dinis Guarda Interviews Jay Steinback, CEO yWhales

Leveraging Blockchain Tech To Transition Businesses To Web 3.0: Dinis Guarda Interviews Jay Steinback, CEO yWhales

Feb 14, 2024
The Trinity MBA Surges 21 Places In The Financial Times’ 2024 Global MBA Ranking

The Trinity MBA Surges 21 Places In The Financial Times’ 2024 Global MBA Ranking

Feb 12, 2024
8 Tips for Improving Transportation and Logistics for Your Business

8 Tips for Improving Transportation and Logistics for Your Business

Feb 12, 2024